REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

Clinical trials for REFRACTORY ACUTE MYELOID LEUKEMIA (AML) explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ACUTE MYELOID LEUKEMIA (AML) trials appear

Sign up with your email to follow new studies for REFRACTORY ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug tested for patients with no other options

Disease control Recruiting now

This is a first-in-human study testing a new drug called STX-0712 in patients with advanced forms of blood cancer (CMML and AML) who have no remaining standard treatment options. The main goals are to find a safe dose and see if the drug shows any early signs of fighting the canc…

Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

Get alerted when new REFRACTORY ACUTE MYELOID LEUKEMIA (AML) trials appear

New drug tested for patients with no other options